Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies
Delphine Vezzosi(Université Toulouse III - Paul Sabatier), Philippe Caron(Hôpital Larrey), J. Selves, Christiane Susini(Inserm), F. Courbon(Institut Claudius Regaud), B. Pradère(Hôpital Purpan), Antoine Bennet(Hôpital Rangueil), Philippe Rochaix(Inserm)
Cited by 183
Related Papers
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
|Annals of Oncology|2015|257
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
|The Journal of Clinical Endocrinology & Metabolism|2019|180
Antitumor effects of somatostatin
|Molecular and Cellular Endocrinology|2008|174